Repligen | RGEN - 股本和储备



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


股本和储备 更改 日
Agilent USD 7.12B 214M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
Bio Techne USD 2.09B 74.32M 2026-03
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Bruker USD 2.44B 67M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.16B 109M 2026-06
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
OraSure Technologies USD 317.78M 4.45M 2026-06
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 15.29B 12.73B 2026-03
West Pharmaceutical Services USD 2.99B 200K 2026-06